Anisamide-targeted cyclodextrin nanoparticles for siRNA delivery to prostate tumours in mice

Siegel, 2011, Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths, CA Cancer J Clin, 61, 212, 10.3322/caac.20121 Masiero, 2007, RNA interference: implications for cancer treatment, Mol Aspects Med, 28, 143, 10.1016/j.mam.2006.12.004 Guo, 2011, Can non-viral technologies knockdown the barriers to siRNA delivery and achieve the next generation of cancer therapeutics, Biotechnol Adv, 29, 402, 10.1016/j.biotechadv.2011.03.003 Whitehead, 2009, Knocking down barriers: advances in siRNA delivery, Nat Rev Drug Discov, 8, 129, 10.1038/nrd2742 Oh, 2009, siRNA delivery systems for cancer treatment, Adv Drug Deliv Rev, 61, 850, 10.1016/j.addr.2009.04.018 Guo, 2010, Therapeutic targeting in the silent era: advances in non-viral siRNA delivery, Mol Biosyst, 6, 1143 Tan, 2011, Engineering nanocarriers for siRNA delivery, Small, 7, 841, 10.1002/smll.201001389 Cryan, 2004, Cationic cyclodextrin amphiphiles as gene delivery vectors, J Drug Del Sci Tech, 14, 57, 10.1016/S1773-2247(04)50006-0 Cryan, 2004, Cell transfection with polycationic cyclodextrin vectors, Eur J Pharm Sci, 21, 625, 10.1016/j.ejps.2004.01.001 McMahon, 2008, Cyclodextrin gene vectors: cell trafficking and the influence of lipophilic chain length, J Drug Del Sci Tech, 18, 303, 10.1016/S1773-2247(08)50060-8 Byrne, 2009, Poly-6-cationic amphiphilic cyclodextrins designed for gene delivery, Org Biomol Chem, 7, 3763, 10.1039/b907232b O'Neill, 2011, Mechanistic studies on the uptake and intracellular trafficking of novel cyclodextrin transfection complexes by intestinal epithelial cells, Int J Pharm, 413, 174, 10.1016/j.ijpharm.2011.04.021 O'Mahony, 2012, A click chemistry route to 2-functionalised PEGylated and cationic β-cyclodextrins: co-formulation opportunities for siRNA delivery, Org Biomol Chem, 10.1039/c2ob25490e Sallas, 2008, Amphiphilic cyclodextrins – advances in synthesis and supramolecular chemistry, Eur J Org Chem, 2008, 957, 10.1002/ejoc.200700933 Mellet, 2011, Cyclodextrin-based gene delivery systems, Chem Soc Rev, 40, 1586, 10.1039/C0CS00019A Diaz-Moscoso, 2011, Mannosyl-coated nanocomplexes from amphiphilic cyclodextrins and pDNA for site-specific gene delivery, Biomaterials, 32, 7263, 10.1016/j.biomaterials.2011.06.025 Arima, 2011, Inhibitory effect of siRNA complexes with polyamidoamine dendrimer/a-cyclodextrin conjugate (generation 3, G3) on endogenous gene expression, Eur J Pharm Sci, 44, 375, 10.1016/j.ejps.2011.08.019 Banerjee, 2004, Anisamide-targeted stealth liposomes: a potent carrier for targeting doxorubicin to human prostate cancer cells, Int J Cancer, 112, 693, 10.1002/ijc.20452 Li, 2008, Efficient gene silencing in metastatic tumor by siRNA formulated in surface-modified nanoparticles, J Control Release, 126, 77, 10.1016/j.jconrel.2007.11.002 Chono, 2008, An efficient and low immunostimulatory nanoparticle formulation for systemic siRNA delivery to the tumor, J Control Release, 131, 64, 10.1016/j.jconrel.2008.07.006 Li, 2010, Biodegradable calcium phosphate nanoparticle with lipid coating for systemic siRNA delivery, J Control Release, 142, 416, 10.1016/j.jconrel.2009.11.008 Kim, 2008, Local and systemic delivery of VEGF siRNA using polyelectrolyte complex micelles for effective treatment of cancer, J Control Release, 129, 107, 10.1016/j.jconrel.2008.03.008 Hobel, 2010, Polyethylenimine/small interfering RNA-mediated knockdown of vascular endothelial growth factor in vivo exerts anti-tumor effects synergistically with bevacizumab, J Gene Med, 12, 287 Choi, 2010, The systemic delivery of siRNAs by a cell penetrating peptide, low molecular weight protamine, Biomaterials, 31, 1429, 10.1016/j.biomaterials.2009.11.001 Guo, 2012, Systemic delivery of therapeutic small interfering RNA using a pH-triggered amphiphilic poly-l-lysine nanocarrier to suppress prostate cancer growth in mice, Eur J Pharm Sci, 45, 521, 10.1016/j.ejps.2011.11.024 Kim, 2001, A novel synthesis of sulfuric acid mono-[2-(2-amino-ethanesulfonyl)-ethyl] ester for use as an intermediate in the preparation of reactive dyes, Synth Commun, 32, 1601, 10.1081/SCC-120004152 Cline, 1988, Kinetics and mechanisms of the aminolysis of N-hydroxysuccinimide esters in aqueous buffers, J Org Chem, 53, 3583, 10.1021/jo00250a031 Fugedi, 1989, Synthesis of heptakis(6-O-tert-butyldimethylsilyl)cyclomaltoheptaose and octakis(6-O-tert-butyldimethylsilyl)cyclomalto-octaose, Carbohydr Res, 192, 366, 10.1016/0008-6215(89)85197-3 Zhang, 1991, Formation of amphiphilic cyclodextrins via hydrophobic esterification at the secondary hydroxyl face, Tetrahedron Lett, 32, 2769, 10.1016/0040-4039(91)85081-F Falvey, 2005, Bilayer vesicles of amphiphilic cyclodextrins: host membranes that recognize guest molecules, Chemistry, 11, 1171, 10.1002/chem.200400905 Li, 2006, Targeted delivery of antisense oligodeoxynucleotide and small interference RNA into lung cancer cells, Mol Pharm, 3, 579, 10.1021/mp060039w Ahmad, 2009, Prostate stem cell antigen DNA vaccination breaks tolerance to self-antigen and inhibits prostate cancer growth, Mol Ther, 17, 1101, 10.1038/mt.2009.66 Li, 2007, Lipid-based nanoparticles for nucleic acid delivery, Pharm Res, 24, 438, 10.1007/s11095-006-9180-5 Marrazzo, 2010, Antiproliferative activity of phenylbutyrate ester of haloperidol metabolite II [(±)-MRJF4] in prostate cancer cells, Eur J Med Chem, 46, 433, 10.1016/j.ejmech.2010.10.012 Colabufo, 2008, PB183, a sigma receptor ligand, as a potential PET probe for the imaging of prostate adenocarcinoma, Bioorg Med Chem Lett, 18, 1990, 10.1016/j.bmcl.2008.01.109 Xiong, 2009, Biodegradable amphiphilic poly(ethylene oxide)-block-polyesters with grafted polyamines as supramolecular nanocarriers for efficient siRNA delivery, Biomaterials, 30, 242, 10.1016/j.biomaterials.2008.09.025